enow.com Web Search

Search results

    15.09+0.45 (+3.07%)

    at Fri, May 31, 2024, 4:00PM EDT - U.S. markets closed

    Nasdaq Real Time Price

    • Open 14.77
    • High 15.21
    • Low 14.64
    • Prev. Close 14.64
    • 52 Wk. High 27.02
    • 52 Wk. Low 13.71
    • P/E N/A
    • Mkt. Cap 1.19B
  1. Results from the WOW.Com Content Network
  2. Prism correction - Wikipedia

    en.wikipedia.org/wiki/Prism_correction

    Eye care professionals use prism correction as a component of some eyeglass prescriptions. A lens which includes some amount of prism correction will displace the viewed image horizontally, vertically, or a combination of both directions. The most common application for this is the treatment of strabismus.

  3. Prism cover test - Wikipedia

    en.wikipedia.org/wiki/Prism_Cover_Test

    The prism cover test ( PCT) is an objective measurement and the gold standard in measuring strabismus, i.e. ocular misalignment, or a deviation of the eye. [1] It is used by ophthalmologists and orthoptists in order to measure the vertical and horizontal deviation and includes both manifest and latent components. [1]

  4. Strabismus surgery - Wikipedia

    en.wikipedia.org/wiki/Strabismus_surgery

    Strabismus surgery (also: extraocular muscle surgery, eye muscle surgery, or eye alignment surgery) is surgery on the extraocular muscles to correct strabismus, the misalignment of the eyes. [1] Strabismus surgery is a one-day procedure that is usually performed under general anesthesia most commonly by either a neuro- or pediatric ...

  5. Hypertropia - Wikipedia

    en.wikipedia.org/wiki/Hypertropia

    Depending on the individual case, treatment options include: Correction of refractive errors by glasses; Prism therapy (if tolerated, to manage diplopia) Vision Therapy; Patching (mainly to manage amblyopia in children and diplopia in adults) Botulinum toxin injection; Surgical correction

  6. Anterior chamber paracentesis - Wikipedia

    en.wikipedia.org/wiki/Anterior_chamber_paracentesis

    Anterior chamber paracentesis (ACP) is a surgical procedure done to reduce intraocular pressure (IOP) of the eye. The procedure is used in management of glaucoma and uveitis. It is also used for clinical diagnosis of infectious uveitis.

  7. Four prism dioptre reflex test - Wikipedia

    en.wikipedia.org/wiki/Four_prism_dioptre_reflex_test

    Four prism dioptre reflex test. Purpose. assess alignment of both eyes. The Four Prism Dioptre Reflex Test (also known as the 4 PRT, or 4 Prism Dioptre Base-out Test) is an objective, non-dissociative test used to prove the alignment of both eyes (i.e. the presence of binocular single vision) by assessing motor fusion. [1]

  8. Anisometropia - Wikipedia

    en.wikipedia.org/wiki/Anisometropia

    Amblyopia. Anisometropia is a condition in which a person's eyes have substantially differing refractive power. [1] Generally, a difference in power of one diopter (1D) is the threshold for diagnosis of the condition . [2] [3] Patients may have up to 3D of anisometropia before the condition becomes clinically significant due to headache, eye ...

  9. Intraocular pressure - Wikipedia

    en.wikipedia.org/wiki/Intraocular_pressure

    Intraocular pressure (IOP) is the fluid pressure inside the eye. Tonometry is the method eye care professionals use to determine this. IOP is an important aspect in the evaluation of patients at risk of glaucoma. Most tonometers are calibrated to measure pressure in millimeters of mercury .

  10. Corrective lens - Wikipedia

    en.wikipedia.org/wiki/Corrective_lens

    A pair of contact lenses, positioned with the concave side facing upward. A corrective lens is a transmissive optical device that is worn on the eye to improve visual perception. The most common use is to treat refractive errors: myopia, hypermetropia, astigmatism, and presbyopia.

  11. Vitreomacular adhesion - Wikipedia

    en.wikipedia.org/wiki/Vitreomacular_adhesion

    The current standard of care for treating these adhesions is pars plana vitrectomy (PPV), which involves surgically removing the vitreous from the eye. A biological agent for non-invasive treatment of adhesions called ocriplasmin has been approved by the FDA on October 17, 2012.